查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011222

植物性因體學市場：按產品類型、技術、應用和最終用戶分類的全球市場預測 – 2026-2032 年

Plant Genomics Market by Product Type, Technology, Application, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，植物性因組學市場價值將達到 122.3 億美元，到 2026 年將成長到 133.1 億美元，到 2032 年將達到 230.9 億美元，複合年成長率為 9.49%。

主要市場統計數據
基準年 2025 122.3億美元
預計年份：2026年 133.1億美元
預測年份 2032 230.9億美元
複合年成長率 (%) 9.49%

對植物性因組學進行策略性介紹，系統地概述了農業、診斷和研究領域的技術整合、營運重點和相關人員需求。

植物性因體學融合了生物學、資料科學和農業創新，其不斷擴展的工具庫正在重新定義相關人員追求生產力、韌性和診斷洞見的方式。編輯平台、擴增和定序技術的進步正在逐步降低技術門檻，使更多機構能夠將基因組學整合到育種計劃、診斷流程和基礎研究中。同時，人們越來越重視資料管理、可重複性和監管清晰度，這些因素共同影響整個價值鏈的投資重點和營運選擇。

技術突破、不斷變化的監管預期以及以服務為中心的模式如何重塑植物性因組學的策略重點和營運流程。

植物性因組學領域正經歷著變革性的轉變，這主要得益於調查方法的飛躍、監管環境的轉變以及終端用戶期望的不斷變化。基因編輯技術正從小眾實驗工具發展成為性狀開發的實用手段，這需要對育種策略和智慧財產權管理等擴充性流程進行相應的調整。同時，定序平台提供了更豐富和複雜的資料集，因此需要投資於可擴展的儲存、標準化的資料格式以及能夠支援跨研究比較和轉換應用的分析框架。

評估近期關稅措施對植物性因組學工作流程中採購、合作和供應的連續性所產生的營運和物流連鎖反應。

近期影響進出口的關稅措施正在整個植物性因組學生態系統中引發新的摩擦，進而影響設備、試劑和許可的採購。對於依賴跨境定序設備和專用試劑供應的實驗室而言，與關稅相關的成本調整可能導致採購計畫的變更和資本規劃的修訂。這些變化將影響實驗室的產能和新計畫的推出速度，尤其對於那些津貼週期緊張或受季節性農業活動影響的機構更是如此。

詳細的細分洞察揭示了產品類型、技術平台、服務模式、應用和最終用戶如何創造植物性因組學領域的差異化價值池。

精準的市場區隔有助於明確價值創造點以及值得投資的能力。相關人員根據產品類型將產品分為儀器、試劑和耗材、服務以及軟體，每種產品都有其獨特的採購週期和支援預期。儀器需要資本規劃和長期服務契約，而試劑和耗材則涉及持續支出和品管問題。服務為缺乏內部能力的實驗室提供以結果為導向的能力，而軟體則支援資料處理、視覺化和決策支援。

影響美洲、歐洲、中東、非洲和亞太地區區域趨勢和戰略意義的因素，包括採用、監管和基礎設施選擇。

區域趨勢影響著人才獲取、資本基礎設施和法規結構，其中三個地理區域叢集尤其引人注目。美洲地區擁有多元化的學術優勢、活躍的創投活動和成熟的產業參與者，有利於基因組工具快速轉化為商業化產品。強大的基礎設施和接近性大規模農業市場的地理優勢促進了高通量定序和基因編輯應用計畫的開展，而區域監管流程則影響臨床試驗設計和產品部署。

競爭對手和策略方法強調平台整合、服務捆綁和資料管治，以此作為植物性因組學提供者之間的差異化因素。

植物性因組學生態系統中的主要企業正透過整合儀器、耗材、軟體和服務等產品組合來脫穎而出。那些將產品藍圖與使用者工作流程相契合併優先考慮互通性的公司，往往能夠降低部署門檻，並提升客戶的長期參與。儀器製造商、試劑供應商和專業服務供應商之間的策略夥伴關係，正在為尋求承包解決方案的機構打造極具吸引力的捆綁式解決方案。

為領導者提供可操作且優先的行動方案，以增強供應鏈韌性、拓展業務並調整商業模式以適應不斷變化的使用者需求。

產業領導企業應制定一系列切實可行的優先事項，以平衡短期韌性和長期能力建構。首先，供應鏈多元化以及對關鍵試劑和設備組件的多個合格供應商進行認證，可以減輕關稅造成的市場波動帶來的營運中斷，並支持業務永續營運。其次，投資模組化自動化和標準化資料管道，可以提高吞吐量，同時減少日常流程的工作量，從而提高可重複性並實現規模化。

我們採用嚴謹的混合方法研究途徑，結合專家訪談、技術文獻綜述和迭代檢驗，確保獲得實用且可操作的見解。

本調查方法結合了定性和定量方法，以確保研究的穩健性和相關性。主要資訊來源包括對學術界、工業界和臨床領域專家的結構化訪談，以及對實驗室管理人員和採購專員的訪談，以檢驗營運限制和採購行為。二級資訊來源包括同儕審查文獻、監管文件、技術白皮書和公開的產品規格，並將這些資料綜合起來，為比較評估提供技術標準。

整合領導者應關注的實用見解和策略重點，以將植物性因組學的進步轉化為可靠的營運和商業性成果。

綜上所述，這些證據凸顯了一個變革時期的植物性因組學生態系統，其中技術成熟度、數據複雜性和供應鏈考量相互交織，重新定義了策略重點。投資於互通平台、彈性採購模式和以結果為導向的服務夥伴關係的相關人員，更有能力將基因組技術能力轉化為實際營運成果。同樣重要的是，要培養能夠銜接實驗室驗證、生物資訊解讀和法規遵循的跨領域團隊。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 植物性因體學市場：依產品類型分類

  • 裝置
  • 試劑和耗材
  • 服務
  • 軟體

第9章：植物性因體學市場：依技術分類

  • 基因編輯
  • 聚合酵素鏈鎖反應
  • 定序
    • 次世代定序
    • 桑格定序
    • 第三代定序

第10章 植物性因體學市場：依應用領域分類

  • 農業
    • 抗病性
    • 遺傳改良
    • 產量提升
  • 診斷
    • 基因檢測
    • 傳染病檢查
    • 產前檢查
  • 調查
    • 基礎研究
    • 生物標記的發現
    • 藥物發現

第11章 植物性因體學市場：依最終用戶分類

  • 學術和研究機構
  • 農業相關企業
  • 醫院和診斷檢測機構
  • 製藥和生物技術公司

第12章 植物性因體學市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：植物性因體學市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 植物性因體學市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國植物性因體學市場

第16章：中國植物性因組市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Bayer AG
  • Benson Hill, Inc.
  • BGI Genomics Co., Ltd.
  • Calyxt, Inc.
  • Corteva Agriscience
  • Eurofins Scientific SE
  • Floragenex, Inc.
  • Illumina, Inc.
  • Inari Agriculture, Inc.
  • KeyGene NV
  • Merck KGaA
  • Neogen Corporation
  • Novogene Co., Ltd.
  • NRGene Technologies Ltd.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • QIAGEN NV
  • Syngenta AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4316E4E8911B

The Plant Genomics Market was valued at USD 12.23 billion in 2025 and is projected to grow to USD 13.31 billion in 2026, with a CAGR of 9.49%, reaching USD 23.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.23 billion
Estimated Year [2026] USD 13.31 billion
Forecast Year [2032] USD 23.09 billion
CAGR (%) 9.49%

A strategic primer on plant genomics that frames technological integration, operational priorities, and stakeholder needs across agriculture, diagnostics, and research

Plant genomics stands at the intersection of biology, data science, and agricultural innovation, and its expanding toolkit is redefining how stakeholders pursue productivity, resilience, and diagnostic insight. Advances in editing platforms, amplification techniques, and sequencing technologies have progressively lowered technical barriers, enabling a broader set of organizations to integrate genomics into breeding programs, diagnostic workflows, and foundational research. This shift is accompanied by a growing emphasis on data management, reproducibility, and regulatory clarity, which together shape investment priorities and operational choices across the value chain.

As the discipline matures, practitioners are navigating increasingly complex supplier networks, evolving standards for genetic tool deployment, and a heightened demand for robust bioinformatics pipelines. In response, cross-disciplinary teams are reorganizing around modular workflows that connect instruments, reagents, analytical software, and services. This integrated approach enhances throughput and interpretability, while also highlighting the need for adaptable procurement strategies and skilled personnel who can translate genomic outputs into actionable decisions for agriculture, diagnostics, and discovery research.

How technological breakthroughs, evolving regulatory expectations, and service-centric models are reshaping strategic priorities and operational workflows in plant genomics

The plant genomics landscape is experiencing transformative shifts driven by methodological breakthroughs, changes in regulatory postures, and evolving end-user expectations. Gene editing technologies have moved from niche experimental tools to practical instruments for trait development, prompting downstream adjustments in breeding strategies and intellectual property management. At the same time, sequencing platforms are delivering richer and more complex datasets, requiring investment in scalable storage, standardized data formats, and analytical frameworks that can support cross-study comparisons and translational applications.

Concurrently, services and software are gaining prominence as organizations prioritize outcomes over in-house instrumentation. This trend encourages collaborative models that pair specialized wet-lab capabilities with advanced computational offerings. Supply chain resilience and sourcing transparency are elevated concerns, prompting a reconsideration of procurement practices. Taken together, these forces are reshaping how organizations allocate capital, design experiments, and structure partnerships, emphasizing agility and downstream value realization over isolated technology acquisition.

Assessing the operational and logistical ripple effects of recent tariff measures on procurement, collaboration, and supply continuity within plant genomics workflows

Recent tariff measures affecting imports and exports have introduced new frictions across the plant genomics ecosystem, influencing procurement of instruments, reagents, and software licensing. For laboratories that rely on cross-border supply of sequencing instruments and specialized reagents, tariff-related cost adjustments can translate into altered procurement timelines and modified capital planning. These dynamics, in turn, affect laboratory throughput and the pace at which new projects are initiated, particularly for organizations operating on tight grant cycles or seasonal agricultural timelines.

Beyond direct cost impacts, tariffs can complicate collaborative research arrangements that depend on timely shipment of samples, consumables, or modular instrument components. As a result, teams increasingly consider regional sourcing alternatives, longer lead times, and contractual safeguards to preserve research continuity. Trade measures also raise the profile of localized manufacturing and distribution strategies, which some stakeholders pursue to mitigate exposure. Importantly, regulatory and customs processes tied to tariff implementation can lengthen clearance times for biological materials and hardware, thereby creating operational bottlenecks that require proactive logistical planning and transparent supplier communication to manage.

Deep segmentation insights revealing how product types, technology platforms, service models, applications, and end users create differentiated value pools across plant genomics

A nuanced understanding of market segmentation clarifies where value is created and which capabilities merit investment. Based on product type, stakeholders classify offerings among instruments, reagents and consumables, services, and software, each carrying distinct procurement cycles and support expectations. Instruments require capital planning and long-term service agreements, reagents and consumables drive recurring spend and quality control concerns, services deliver outcome-oriented capacity for labs lacking in-house capability, and software underpins data processing, visualization, and decision support.

Based on technology, the domain encompasses gene editing, polymerase chain reaction, and sequencing platforms. Gene editing itself is differentiated by CRISPR, transcription activator-like effector nucleases, and zinc finger nucleases, each varying in specificity, delivery approaches, and regulatory scrutiny. Polymerase chain reaction modalities include digital PCR, quantitative PCR, and reverse transcription PCR, which serve distinct applications from absolute quantitation to expression analysis. Sequencing technologies span next-generation, Sanger, and third-generation modalities, offering trade-offs among read length, throughput, and error profiles.

Based on service model, organizations rely on consulting, contract research, and data analysis to augment internal capabilities and accelerate project timelines. These models enable access to specialized expertise and infrastructure without the fixed costs of full ownership. Based on application, use cases map to agriculture, diagnostics, and research. Agricultural applications focus on disease resistance, genetic improvement, and yield enhancement, while diagnostics emphasize genetic testing, infectious disease testing, and prenatal testing. Research spans basic inquiry, biomarker discovery, and drug discovery, each demanding different experimental designs and validation pathways. Based on end users, adoption patterns are driven by academic and research institutes, agricultural firms, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology companies, with each group prioritizing different performance attributes, compliance needs, and service expectations.

Regional dynamics and strategic implications across the Americas, Europe-Middle East-Africa, and Asia-Pacific that influence adoption, regulation, and infrastructure choices

Regional dynamics shape access to talent, capital infrastructure, and regulatory frameworks, and three geographic clusters merit focused attention. The Americas region exhibits a diverse mix of academic excellence, venture activity, and established industrial players, supporting rapid translation of genomic tools into commercial pipelines. Infrastructure strength and proximity to large agricultural markets encourage adoption of both high-throughput sequencing and applied gene editing programs, while regional regulatory processes influence trial design and product deployment.

Europe, the Middle East, and Africa present a varied landscape with progressive research hubs, differentiated regulatory environments, and distinct agricultural priorities. Fragmentation across jurisdictions creates both challenges and opportunities: harmonized regulatory approaches can accelerate cross-border collaborations, whereas divergent rules incentivize localized strategies and partnerships with regional service providers. Meanwhile, parts of the region emphasize sustainable agriculture and biodiversity conservation, which affects research agendas and stakeholder engagement models.

Asia-Pacific is characterized by fast-growing R&D investments, an expanding base of skilled practitioners, and strong governmental initiatives to modernize agriculture and public health diagnostics. Supply chain integration across manufacturing hubs and end-user markets enables scale advantages for reagent and instrument suppliers, while national policies around biotechnology and biosafety shape permissible applications and commercialization pathways. Each region's unique mix of scientific capacity, policy orientation, and market demand requires tailored go-to-market approaches and localized partnerships to maximize impact.

Competitive dynamics and strategic playbooks that highlight platform integration, service bundling, and data governance as differentiators among plant genomics providers

Leading players in the plant genomics ecosystem differentiate themselves through integrated portfolios that combine instrumentation, consumables, software, and service offerings. Companies that align product roadmaps with user workflows and emphasize interoperability tend to reduce adoption friction and increase customer lifetime engagement. Strategic partnerships between instrument manufacturers, reagent suppliers, and specialized service providers create bundled solutions that appeal to organizations seeking turnkey capabilities.

Innovation pathways often center on platform scalability, ease of use, and data integration. Vendors who provide robust training, certification, and application support lower the barrier to adoption in non-traditional end users, such as agricultural firms with limited molecular biology experience. Additionally, firms that invest in secure, compliant cloud environments and transparent data governance practices address a growing set of buyer concerns related to data residency and reproducibility. Contract research organizations and consulting providers that can demonstrate reproducible project outcomes and flexible delivery models are increasingly selected by clients prioritizing speed to insight over capital investment in new instrumentation.

Practical and prioritized actions for leaders to strengthen supply resilience, scale operations, and align commercial models with evolving user needs

Industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term capability building. First, diversifying supply chains and qualifying multiple vetted suppliers for critical reagents and instrument components will reduce operational disruption and support continuity during tariff-driven market shifts. Second, investing in modular automation and standardized data pipelines enhances throughput while lowering the personnel burden of routine processes, thereby improving reproducibility and enabling scale.

Third, deepen collaborations with regional partners and contract research providers to access local expertise, share risk, and accelerate project timelines without overcommitting fixed capital. Fourth, prioritize transparent data governance and cybersecurity measures to build trust with end users and satisfy evolving regulatory requirements. Fifth, design flexible commercial models that combine hardware, consumables, and outcome-oriented services to meet diverse buyer preferences. Finally, build cross-functional teams that integrate domain scientists, bioinformaticians, and regulatory specialists to ensure that product development and deployment decisions align with real-world operational constraints and stakeholder expectations.

A rigorous mixed-method research approach combining expert interviews, technical literature review, and iterative validation to ensure practical and actionable insights

The research methodology combines qualitative and quantitative approaches to ensure robustness and relevance. Primary inputs include structured interviews with domain experts across academia, industry, and clinical settings, alongside consultations with laboratory operations managers and procurement specialists to validate operational constraints and purchasing behaviors. Secondary inputs encompass peer-reviewed literature, regulatory documents, technical white papers, and publicly available product specifications, which together provide a technical baseline for comparative assessment.

Data triangulation was applied to reconcile insights from diverse sources, and thematic analysis identified recurrent operational challenges, technology adoption drivers, and supplier positioning. Throughout the process, iterative validation sessions with subject matter experts refined interpretations and ensured that practical considerations-such as reagent lifecycle management, instrument calibration needs, and data interoperability requirements-were accurately represented. The resulting framework integrates product, technology, service, application, and end-user perspectives to support decision making without relying on single-source assumptions.

Synthesis of practical implications and strategic priorities that leaders must address to convert plant genomics advancements into reliable operational and commercial outcomes

The collective evidence highlights a plant genomics ecosystem in transition, where technological maturity, data complexity, and supply chain considerations intersect to redefine strategic priorities. Stakeholders who invest in interoperable platforms, resilient procurement models, and outcome-oriented service partnerships are better positioned to translate genomic capabilities into operational impact. Equally important is the cultivation of multidisciplinary teams that can bridge wet-lab execution with bioinformatic interpretation and regulatory navigation.

Looking ahead, success will be determined less by single technology choices and more by the ability to assemble adaptable workflows that meet specific application needs, whether in agriculture, diagnostics, or foundational research. Organizations that balance near-term operational resilience with long-term investments in automation, data governance, and regional partnerships will navigate present challenges while preserving optionality to capitalize on future innovations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plant Genomics Market, by Product Type

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
  • 8.3. Services
  • 8.4. Software

9. Plant Genomics Market, by Technology

  • 9.1. Gene Editing
  • 9.2. Polymerase Chain Reaction
  • 9.3. Sequencing
    • 9.3.1. Next Generation Sequencing
    • 9.3.2. Sanger Sequencing
    • 9.3.3. Third Generation Sequencing

10. Plant Genomics Market, by Application

  • 10.1. Agriculture
    • 10.1.1. Disease Resistance
    • 10.1.2. Genetic Improvement
    • 10.1.3. Yield Improvement
  • 10.2. Diagnostics
    • 10.2.1. Genetic Testing
    • 10.2.2. Infectious Disease Testing
    • 10.2.3. Prenatal Testing
  • 10.3. Research
    • 10.3.1. Basic Research
    • 10.3.2. Biomarker Discovery
    • 10.3.3. Drug Discovery

11. Plant Genomics Market, by End Users

  • 11.1. Academic & Research Institutes
  • 11.2. Agriculture Firms
  • 11.3. Hospitals & Diagnostic Laboratories
  • 11.4. Pharmaceutical & Biotechnology Companies

12. Plant Genomics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Plant Genomics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Plant Genomics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Plant Genomics Market

16. China Plant Genomics Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Bayer AG
  • 17.7. Benson Hill, Inc.
  • 17.8. BGI Genomics Co., Ltd.
  • 17.9. Calyxt, Inc.
  • 17.10. Corteva Agriscience
  • 17.11. Eurofins Scientific SE
  • 17.12. Floragenex, Inc.
  • 17.13. Illumina, Inc.
  • 17.14. Inari Agriculture, Inc.
  • 17.15. KeyGene N.V.
  • 17.16. Merck KGaA
  • 17.17. Neogen Corporation
  • 17.18. Novogene Co., Ltd.
  • 17.19. NRGene Technologies Ltd.
  • 17.20. Oxford Nanopore Technologies plc
  • 17.21. Pacific Biosciences of California, Inc.
  • 17.22. QIAGEN N.V.
  • 17.23. Syngenta AG
  • 17.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLANT GENOMICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PLANT GENOMICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PLANT GENOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PLANT GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)